Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume – What’s Next?

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) saw unusually-high trading volume on Monday . 190,420 shares traded hands during mid-day trading, an increase of 585% from the previous session’s volume of 27,797 shares.The stock last traded at $9.68 and had previously closed at $9.5750.

Analyst Ratings Changes

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Nihon Kohden has an average rating of “Buy”.

Nihon Kohden Stock Performance

The business’s 50 day moving average price is $9.00 and its two-hundred day moving average price is $9.92. The company has a market capitalization of $1.63 billion, a price-to-earnings ratio of 16.40 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The business had revenue of $453.10 million during the quarter, compared to analysts’ expectations of $414.40 million. On average, sell-side analysts expect that Nihon Kohden Corporation will post 0.6 earnings per share for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.